These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19435406)

  • 41. Selective drug delivery approaches to lesioned brain through blood brain barrier disruption.
    Al-Ahmady ZS
    Expert Opin Drug Deliv; 2018 Apr; 15(4):335-349. PubMed ID: 29466890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Research advances in brain-targeted nanoscale drug delivery system].
    Liu Y; Jiang C
    Yao Xue Xue Bao; 2013 Oct; 48(10):1532-43. PubMed ID: 24417079
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evolving Drug Delivery Strategies to Overcome the Blood Brain Barrier.
    Hersh DS; Wadajkar AS; Roberts N; Perez JG; Connolly NP; Frenkel V; Winkles JA; Woodworth GF; Kim AJ
    Curr Pharm Des; 2016; 22(9):1177-1193. PubMed ID: 26685681
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A review of chitosan-based nanocarriers as drug delivery systems for brain diseases: Critical challenges, outlooks and promises.
    Khodaverdi K; Bakhshi A; Mozafari MR; Naghib SM
    Int J Biol Macromol; 2024 Oct; 278(Pt 3):134962. PubMed ID: 39179064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nanoparticulate systems for brain delivery of drugs.
    Kreuter J
    Adv Drug Deliv Rev; 2001 Mar; 47(1):65-81. PubMed ID: 11251246
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vector-mediated drug delivery to the brain.
    Temsamani J; Rousselle C; Rees AR; Scherrmann JM
    Expert Opin Biol Ther; 2001 Sep; 1(5):773-82. PubMed ID: 11728213
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Development of Polymeric Nanoparticles for Blood-Brain Barrier Transfer-Strategies and Challenges.
    Zhang W; Mehta A; Tong Z; Esser L; Voelcker NH
    Adv Sci (Weinh); 2021 May; 8(10):2003937. PubMed ID: 34026447
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Updated Progress of Nanocarrier-Based Intranasal Drug Delivery Systems for Treatment of Brain Diseases.
    Fan Y; Chen M; Zhang J; Maincent P; Xia X; Wu W
    Crit Rev Ther Drug Carrier Syst; 2018; 35(5):433-467. PubMed ID: 30317945
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Perspectives on Dual Targeting Delivery Systems for Brain Tumors.
    Gao H
    J Neuroimmune Pharmacol; 2017 Mar; 12(1):6-16. PubMed ID: 27270720
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transporting therapeutics across the blood-brain barrier.
    Abbott NJ; Romero IA
    Mol Med Today; 1996 Mar; 2(3):106-13. PubMed ID: 8796867
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [New protein vectors for physiological transfer of therapeutic agents to the central nervous system].
    Gabathuler R
    Biol Aujourdhui; 2012; 206(3):191-203. PubMed ID: 23171842
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The role of peptides in blood-brain barrier nanotechnology.
    Teixidó M; Giralt E
    J Pept Sci; 2008 Feb; 14(2):163-73. PubMed ID: 18085720
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Emerging blood-brain-barrier-crossing nanotechnology for brain cancer theranostics.
    Tang W; Fan W; Lau J; Deng L; Shen Z; Chen X
    Chem Soc Rev; 2019 Jun; 48(11):2967-3014. PubMed ID: 31089607
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Medicinal chemistry based approaches and nanotechnology-based systems to improve CNS drug targeting and delivery.
    Vlieghe P; Khrestchatisky M
    Med Res Rev; 2013 May; 33(3):457-516. PubMed ID: 22434495
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Research Progress on the Strategies for Crossing the Blood-Brain Barrier.
    Qiao L; Du X; Wang H; Wang Z; Gao S; Zhao CQ
    Mol Pharm; 2024 Oct; 21(10):4786-4803. PubMed ID: 39231367
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Recent advances in delivery through the blood-brain barrier.
    Larsen JM; Martin DR; Byrne ME
    Curr Top Med Chem; 2014; 14(9):1148-60. PubMed ID: 24678707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nanoneurotherapeutics approach intended for direct nose to brain delivery.
    Md S; Mustafa G; Baboota S; Ali J
    Drug Dev Ind Pharm; 2015; 41(12):1922-34. PubMed ID: 26057769
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanoparticle enabled drug delivery across the blood brain barrier: in vivo and in vitro models, opportunities and challenges.
    Gidwani M; Singh AV
    Curr Pharm Biotechnol; 2014; 14(14):1201-12. PubMed ID: 24809717
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipid Nanocarriers for Enhanced Delivery of Temozolomide to the Brain.
    Khosa A; Krishna KV; Dubey SK; Saha RN
    Methods Mol Biol; 2020; 2059():285-298. PubMed ID: 31435928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Polymeric nanoparticles for the drug delivery to the central nervous system.
    Tosi G; Costantino L; Ruozi B; Forni F; Vandelli MA
    Expert Opin Drug Deliv; 2008 Feb; 5(2):155-74. PubMed ID: 18248316
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.